• Home
Professional article
English

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

ContributorsBoccardi, Marina; Festari, Cristina; Altomare, Daniele; Gandolfo, Federica; Orini, Stefania; Nobili, Flavio; Frisoni, Giovanni
Published inEuropean Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, p. 1470-1486
Publication date2018
Abstract

FDG-PET is frequently used as a marker of synaptic damage to diagnose dementing neurodegenerative disorders. We aimed to adapt the items of evidence quality to FDG-PET diagnostic studies, and assess the evidence available in current literature to assist Delphi decisions for European recommendations for clinical use.

Keywords
  • Dementia/diagnostic imaging
  • Fluorodeoxyglucose F18
  • Humans
  • Positron-Emission Tomography
  • Sensitivity and Specificity
Affiliation entities
Research groups
Citation (ISO format)
BOCCARDI, Marina et al. Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia. In: European Journal of Nuclear Medicine and Molecular Imaging, 2018, vol. 45, n° 9, p. 1470–1486. doi: 10.1007/s00259-018-4024-1
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1619-7070
375views
0downloads

Technical informations

Creation04/01/2019 16:23:00
First validation04/01/2019 16:23:00
Update time15/03/2023 15:43:06
Status update15/03/2023 15:43:05
Last indexation02/10/2024 20:44:40
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack